FutureNet has been providing medical records services and technology for more than 20 years and provides visibility to cost, quality, turnaround time and other key performance indicators (KPIs) for its medical transcription, coding and billing services.
The company is already an approved medical transcription services provider for HealthTrust and is currently recognized as Best in KLAS for transcription services and software by healthcare research firm KLAS.
FutureNet Technologies Corporation provides medical transcription, coding and billing services supported by proprietary cloud-based SaaS technology.
Founded in 1996, the company's SSAE 16/SOC 2 audited Stage 2 certified EHR products are used to support their service offerings in hundreds of hospitals and other healthcare organizations nationwide.
HealthTrust serves over 1,400 acute care facilities and more than 22,600 other locations, including ambulatory surgery centers, physician practices, long-term care and alternate care sites.
Headquartered in Brentwood, Tennessee, HealthTrust is integrated with Parallon Business Solutions, LLC a provider of healthcare business and operational services, including revenue cycle management and technology solutions.
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
AbbVie announces interim evaluation of Atogepant Phase three, open-label 156-week extension study
Precision Epigenomics partners with TruDiagnostic
Modalis partners with Ginkgo Bioworks
Stamford Pharmaceuticals starts locally advanced basal cell carcinoma (laBCC) trial of SP-002
Algiax Pharmaceuticals reveals update on chronic neuropathic pain study